Cancer Geneticists study the genetic mutations and alterations that contribute to the development, progression, and spread of cancer. By analyzing DNA sequences and genetic variations, they work to identify specific mutations that may predispose individuals to certain cancers or drive the growth of tumors. Their research is essential for understanding how inherited genetic factors, as well as acquired mutations during a person’s lifetime, influence cancer risk. Through this understanding, cancer geneticists contribute to the development of genetic screening tools, allowing for early detection of cancers and better prevention strategies, particularly for individuals with a family history of cancer.
Identifying genetic risk factors, cancer geneticists also play a pivotal role in the development of personalized medicine. By examining the genetic makeup of both the patient and their cancer, they can help tailor treatment plans to target the specific mutations driving the disease. This approach helps optimize treatment effectiveness and minimize side effects. Cancer geneticists also collaborate closely with molecular oncologists to discover new therapies aimed at targeting genetic abnormalities in cancer cells. Their work is advancing precision medicine, making it possible to not only treat cancer more effectively but to understand the genetic blueprint of each cancer, ultimately leading to more personalized, effective, and sustainable treatments. Through ongoing research, cancer geneticists continue to provide critical insights that will shape the future of cancer prevention and treatment.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China